M42 Appoints Dimitris Moulavasilis as Interim Group COO
- EXEC
- 31/08/2024
M42 Appoints Dimitris Moulavasilis as Interim Group COO
READ MOREM42 Appoints Dimitris Moulavasilis as Interim Group COO
READ MOREBD Names Michael Feld as President of Life Sciences Segment
READ MOREMesse Düsseldorf Restructures Operations, Makes Management Changes
READ MORERyan Schroeder Retires as CRB President and CEO; Lee Emel Named Interim CEO
READ MOREBoston Scientific Elects David Habiger to Board of Directors
READ MORESTALICLA Appoints Dr. Purnanand Sarma, PhD, as Chair of the Board of Directors
READ MOREBotond Roska and José-Alain Sahel Win the Wolf Prize 2024 in the Field of Medicine
READ MOREABOUT Healthcare Appoints Veteran Sales Executive as Chief Revenue Officer
READ MOREDr. Carolyn L. Rochester Wins ATS Assembly on Pulmonary Rehabilitation Lifetime Achievement Award
READ MORE